Yermak’s Resignation Sends Shockwaves Through Kyiv and Europe
The resignation of Andriy Yermak after anti-corruption raids disrupts Ukraine’s leadership and triggers uncertainty across Europe during a critical phase of the war.
Scotland's ambition to achieve net zero emissions by 2045 entails an estimated annual investment of £750 million over the next 20 years. The Climate Change Committee warns that without immediate, large-scale action, including rapid adoption of electric vehicles and heat pumps, the nation risks missing its legally binding climate targets.
The resignation of Andriy Yermak after anti-corruption raids disrupts Ukraine’s leadership and triggers uncertainty across Europe during a critical phase of the war.
Beijing calls on London to publicly endorse One-China, signalling a push for strategic alignment as China confronts Tokyo over Taiwan.
After weeks of tax rumour and expectation-setting, the 26 November Budget landed as a welfare-first package that lifts the benefits cap but tightens the screw on household incomes,
The European Parliament on 13 November 2025 approved amendments that sharply reduce the scope of the Corporate Sustainability Due Diligence Directive and the associated reporting regime
The FTSE 100 hit a record 9,787 points as investors cheered progress in Washington towards ending the US government shutdown. Strong gains in Diageo, miners and financial stocks
Reappointed French Prime Minister Sébastien Lecornu unveiled his second cabinet and must deliver the 2026 budget within days. With opposition parties preparing a no-confidence motion and markets showing
As Ukraine rebuilds from war, music is emerging as a vital force for healing, unity and national renewal.
Optimism, strategy and late-night gossip: Beverley Nielsen shares her experience of Labour’s four-day conference in Liverpool.
Mega‑mergers are surging in 2025, with Q3 deal values exceeding $1 trillion. Big names include Union Pacific’s $85 billion rail deal, Synopsys acquiring Ansys, and the creation of Paramount Skydance.
The UK government is reportedly prepared to allow higher NHS medicine prices to defuse U.S. threats of 100 percent tariffs on branded drugs. The shift comes as pharmaceutical firms